A CT scan can show brain changes associated with Alzheimer’s disease, but it cannot definitively diagnose it. What CT does well is reveal shrinkage in specific brain regions and rule out other causes of cognitive decline, like tumors, blood clots, or fluid buildup. It’s a useful first step, not a final answer.
What a CT Scan Actually Shows
Alzheimer’s disease gradually destroys brain tissue, and that physical loss does show up on CT. The two most visible signs are enlarged ventricles (the fluid-filled spaces inside the brain) and widened sulci (the grooves on the brain’s surface). Both indicate that brain tissue has shrunk, leaving more empty space. Researchers identified these patterns on CT as early as the 1980s, and they remain part of how doctors evaluate dementia today.
One of the most useful CT findings is shrinkage of the medial temporal lobe, the brain region closely tied to memory. Doctors rate this using the MTA scale, scoring it from 0 (no atrophy) to 4 (severe atrophy). This rating system was originally developed for MRI but has been validated for CT scans with similar accuracy. In clinical practice, many memory clinics use a brain CT as the first imaging step, paying close attention to this medial temporal lobe score alongside any signs of vascular damage.
The problem is that these changes only become clearly visible after significant brain tissue has already been lost. In the earliest stages of Alzheimer’s, when symptoms are mild and the brain hasn’t shrunk much, a CT scan may look essentially normal. A doctor might compare your scan to what’s expected for someone your age and size, or to a previous scan if one exists, but subtle early changes are easy to miss.
Why CT Can’t Confirm Alzheimer’s on Its Own
Brain shrinkage isn’t unique to Alzheimer’s. It happens with normal aging, other forms of dementia, depression, chronic alcohol use, and several other conditions. A CT scan can show that something is wrong, but it can’t tell you exactly what’s causing the damage. No single test can diagnose Alzheimer’s disease. The diagnosis comes from combining brain imaging with cognitive testing, medical history, blood work, and sometimes more specialized scans that look for the amyloid plaques and tau tangles that define the disease at a biological level.
CT also has a resolution disadvantage. It’s less detailed than MRI when it comes to soft tissue contrast, which means small or early changes in brain structure can go unnoticed. For detecting white matter damage (a hallmark of vascular contributions to dementia), CT picks up abnormalities with about 71% sensitivity compared to MRI’s 95%. That gap matters most in early or borderline cases, where the changes are subtle.
What CT Is Best At: Ruling Out Other Causes
The biggest value of a CT scan in a dementia workup isn’t confirming Alzheimer’s. It’s making sure nothing else is causing the symptoms. Several treatable conditions can mimic dementia, and CT is fast and effective at spotting them:
- Tumors pressing on brain tissue and disrupting cognition
- Normal pressure hydrocephalus, a buildup of cerebrospinal fluid that causes memory problems, difficulty walking, and bladder issues, and is often reversible with treatment
- Chronic subdural hematoma, a slow bleed between the brain and skull that can develop after even a minor head injury, especially in older adults
- Strokes or areas of dead brain tissue that point toward vascular dementia rather than Alzheimer’s
Finding one of these conditions can completely change the treatment plan. That’s why imaging is a standard part of any dementia evaluation, even when Alzheimer’s is the leading suspicion.
When CT Is Used Instead of MRI
MRI provides more detail and is generally the preferred scan for evaluating dementia. But CT remains common for practical reasons. It’s faster, more widely available, and it’s the go-to option for anyone who can’t have an MRI, such as people with pacemakers, certain metal implants, or severe claustrophobia. For assessing overall brain atrophy and ruling out structural problems, CT and MRI have been shown to perform with comparable accuracy in autopsy-confirmed cases of Alzheimer’s, vascular dementia, and mixed dementia.
If your doctor orders a CT rather than an MRI, it doesn’t mean you’re getting an inferior evaluation. It means the CT can answer the most pressing questions: is the brain shrinking in a pattern consistent with dementia, and is there something else going on that needs immediate attention?
AI Tools Are Improving CT’s Usefulness
One limitation of CT has always been that interpreting brain volume by eye is imprecise. Radiologists can spot obvious atrophy, but quantifying exactly how much brain tissue has been lost is difficult on a standard CT. Newer deep learning tools are changing this. Researchers have developed AI models that can automatically segment a CT scan into gray matter, white matter, and cerebrospinal fluid, then measure the volume of each. These automated measurements correlate with established biomarkers of neurodegeneration, which means CT scans could eventually provide more objective, quantitative data about brain health rather than relying solely on a radiologist’s visual impression.
These tools aren’t yet standard in most clinics, but they represent a shift toward getting more diagnostic value out of a scan that millions of people already receive as part of routine medical care.
What to Expect From Your Results
If you or a family member is getting a CT scan as part of a memory evaluation, the report will typically describe the overall size of the brain’s ventricles and sulci, note any focal areas of damage (like old strokes), and may comment on medial temporal lobe atrophy. A normal-looking CT doesn’t rule out early Alzheimer’s, and an abnormal one doesn’t confirm it. Either way, the scan is one piece of a larger diagnostic picture that your doctor will interpret alongside everything else they know about the situation.
If the CT raises concerns about Alzheimer’s-pattern atrophy and more detail is needed, the next step is typically an MRI. In some cases, a PET scan may follow to look for the protein deposits that are the hallmark of Alzheimer’s at the molecular level, something no structural scan, whether CT or MRI, can detect.